Tolerance Bio licenses clinical-stage IL-7 therapy from NeoImmuneTech

Merck and Moderna report positive Phase 3 melanoma trial results

Scancell announces UK authorisation for Phase 3 melanoma trial

Harbour BioMed IND for HBM7004 approved by China's NMPA

Can-Fite reports preclinical data supporting Phase IIb pancreatic cancer study

Galmed reports positive preclinical results for Aramchol in prostate cancer

AstraZeneca reports positive Phase III results for Tagrisso and Orpathys

HUTCHMED reports positive Phase III results for ORPATHYS and TAGRISSO combination

BioSapien nominated in 'Best Startup' category for 20th Prix Galien USA Awards

Phanes Therapeutics' Spevatamig receives US FDA Fast Track designation in advanced and metastatic biliary tract carcinoma

Rigel's VEPPANU (vepdegestrant) available for patients with ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer

Elephas Biosciences partners Neuberg Diagnostics

Pilot Project between BioCytics and LIDE Biotech

EQL licenses Memprex for Hungarian market through Pharmacenter

Natera to support Phase 1 trial of Kupando's immunotherapy in advanced skin cancers